Cargando…

Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies

Detalles Bibliográficos
Autores principales:	Tao, Fangfang, Zhang, Zhiqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203627/ https://www.ncbi.nlm.nih.gov/pubmed/37229257 http://dx.doi.org/10.3389/fphar.2023.1208518

Ejemplares similares

Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies
por: Gulei, Diana, et al.
Publicado: (2020)

Editorial: Epigenetic regulation and therapy resistance in cancer
por: Zhu, Yongxia, et al.
Publicado: (2023)

Editorial: Novel therapeutic approaches to target drug resistant tumors
por: Riganti, Chiara, et al.
Publicado: (2023)

Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer
por: Dong, Bo, et al.
Publicado: (2020)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Editorial: Therapeutic Drug Monitoring in Solid Organ Transplantation
por: Staatz, Christine E., et al.
Publicado: (2021)

Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
por: Battistelli, Cecilia, et al.
Publicado: (2020)

Editorial: Natural Product Epigenetic Modulators and Inhibitors
por: Ntie-Kang, Fidele, et al.
Publicado: (2021)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
por: Patnaik, Srinivas, et al.
Publicado: (2019)

PHD Finger Protein 19 Enhances the Resistance of Ovarian Cancer Cells to Compound Fuling Granule by Protecting Cell Growth, Invasion, Migration, and Stemness
por: Ruan, Shanming, et al.
Publicado: (2020)

Editorial: Immunity in the development of anti-cancer drug resistance
por: Meng, Ya, et al.
Publicado: (2022)

Editorial: Advanced chemical and material tools to enhance the therapeutic effect of drugs
por: Ihsan, Ayesha, et al.
Publicado: (2023)

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
por: Shao, Zhuo, et al.
Publicado: (2021)

Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
por: Battistelli, Cecilia, et al.
Publicado: (2022)

Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
por: Zhou, Fanfan, et al.
Publicado: (2022)

Editorial: Natural compounds regulating epigenetics for treating chronic inflammatory diseases
por: Zhang, Mingyu, et al.
Publicado: (2023)

Editorial: Phytochemical-based nanoformulations to tackle drug resistance in cancer
por: Tuli, Hardeep Singh, et al.
Publicado: (2023)

Editorial: New drugs, approaches, and strategies to combat antimicrobial resistance
por: Singh, Chandra Kant, et al.
Publicado: (2023)

Editorial: Therapeutic potential of natural products-based drugs in regulation of lipid metabolism
por: Rašković, Aleksandar, et al.
Publicado: (2023)

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
por: Gunosewoyo, Hendra, et al.
Publicado: (2023)

Editorial: Therapeutic strategies for drug-induced liver injury: Review of the current literature
por: Robles-Díaz, Mercedes, et al.
Publicado: (2022)

The Breast Cancer Stem Cells Traits and Drug Resistance
por: Zheng, Qinghui, et al.
Publicado: (2021)

Editorial: Therapeutic implications of circadian rhythms
por: Yang, Guangrui, et al.
Publicado: (2015)

Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension
por: Wang, Yu, et al.
Publicado: (2018)

Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology
por: Battistelli, Cecilia, et al.
Publicado: (2021)

Editorial: Environmental Enrichment as a Treatment? Epigenetic Mechanisms, Challenges and Limitations
por: Redolat, Rosa, et al.
Publicado: (2021)

LINC01116 Promotes Doxorubicin Resistance in Osteosarcoma by Epigenetically Silencing miR-424-5p and Inducing Epithelial-Mesenchymal Transition
por: Li, Ran, et al.
Publicado: (2021)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis
por: Skibba, Melissa, et al.
Publicado: (2020)

Editorial: Plant-based drugs: the potential novel therapeutic intervention against cancer stemness and metastasis
por: Liju, Vijayasteltar B., et al.
Publicado: (2023)

Editorial: Therapeutic Index for Nutraceuticals in Inflammation-Related Diseases: Efficacy, Bioavailability, Metabolism and Interactions With Drugs
por: Peluso, Ilaria, et al.
Publicado: (2020)

Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?
por: Jaafari, Abdeslam, et al.
Publicado: (2022)

Epigenetics and Vascular Senescence–Potential New Therapeutic Targets?
por: Ding, Qian, et al.
Publicado: (2020)

Editorial: Prodrug design and therapeutic applications
por: Xiao, Qicai, et al.
Publicado: (2023)

Editorial: Therapeutic Advances in Melatonin Research
por: López-Muñoz, Francisco, et al.
Publicado: (2022)

Editorial: Plant products for antiviral therapeutics
por: Mandal, Anirban, et al.
Publicado: (2022)

Toward Therapeutic Drug Monitoring of Lenalidomide in Hematological Malignancy? Results of an Observational Study of the Exposure-Safety Relationship
por: Song, Zaiwei, et al.
Publicado: (2022)

Editorial: The Challenge of New Therapeutic Approaches for Unmet Therapeutic Needs
por: Rosa, Arianna Carolina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r8p8vl2porhjk2ps63e7mtje11